Reaction
Application Site Dryness reporting signals
As of the last recalculation, Application Site Dryness appears in 3,369 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 176.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil Foam 5% (Womens) | 738 | 176.7 | 180.7 |
| Minoxidil | 821 | 149.0 | 151.7 |
| Glycerin, Lidocaine | 68 | 30.6 | 30.7 |
| Tretinoin | 39 | 30.0 | 30.2 |
| Docosanol | 68 | 29.2 | 29.4 |
| Methylphenidate | 98 | 21.5 | 21.6 |
| Nicotine | 73 | 11.4 | 11.4 |
| Crisaborole | 17 | 11.0 | 11.0 |
| Buprenorphine | 128 | 8.8 | 8.9 |
| Dapsone | 13 | 7.5 | 7.6 |
| Estradiol | 74 | 5.4 | 5.4 |
| Clobetasol Propionate | 9 | 5.4 | 5.4 |
| Ketoconazole | 14 | 5.0 | 5.0 |
| Clobetasol Propionate Ointment Usp, 0.05% | 8 | 4.8 | 4.8 |
| Ketoconazole Cream, 2% | 11 | 4.6 | 4.6 |
| Ketoconazole Foam | 10 | 4.2 | 4.2 |
| Oxybutynin | 17 | 3.6 | 3.6 |
| Adapalene | 95 | 3.3 | 3.3 |
| Granisetron | 5 | 2.9 | 2.9 |
| Salicylic Acid | 17 | 2.0 | 2.0 |